Sacubitril/Valsartan: The newest addition to the toolbox for guideline-directed medical therapy of heart failure

JE Rodgers - The American journal of medicine, 2017 - Elsevier
Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor blocker. As
an inhibitor of neprilysin, an enzyme that degrades biologically active natriuretic peptides …

Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure

JE Rodgers - The American Journal of Medicine, 2017 - amjmed.com
Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor blocker. As
an inhibitor of neprilysin, an enzyme that degrades biologically active natriuretic peptides …

Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure.

JE Rodgers - The American Journal of Medicine, 2017 - europepmc.org
Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor blocker. As
an inhibitor of neprilysin, an enzyme that degrades biologically active natriuretic peptides …

Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure

JE Rodgers - The American Journal of Medicine, 2017 - infona.pl
Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor blocker. As
an inhibitor of neprilysin, an enzyme that degrades biologically active natriuretic peptides …

Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure

JE Rodgers - The American journal of medicine, 2017 - pubmed.ncbi.nlm.nih.gov
Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor blocker. As
an inhibitor of neprilysin, an enzyme that degrades biologically active natriuretic peptides …